-
-
What is your level of knowledge when it comes to genital herpes, its methods of virus transmission, risks to others, and appropriate treatment? If results of an online survey are any indication, many health care providers and patients with herpes are poorly informed about herpes.
-
While you may be comfortable with menstrual suppression through use of continuous oral contraceptives (OCs), are your patients? According to results from a national survey, more than 66% of women say that they are interested in suppressing their menstrual periods, but many of them aren't sure if it's safe.
-
New research indicates that a rapid test that uses self-collected vaginal swabs may be effective in diagnosing chlamydia.1 With its ability to deliver results in less than 30 minutes, the test, now in development, would give clinicians a same-day diagnostic and screening tool for chlamydial infection.
-
Review the number of sexually transmitted diseases (STDs) detected in your patient population over the last year.
-
Could a new combined oral contraceptive (OC) be available to U.S. women? Organon is conducting two Phase 3a trials for the first monophasic oral contraceptive containing estradiol (E2) and a new progestin, nomegestrol acetate (NOMAC).
-
Good news for your older female patients: Calcium, or calcium in combination with vitamin D, may prevent osteoporosis in those age 50 and older, results from a new meta-analysis show.
-
When men leave your family planning clinic, they may leave with a supply of condoms in hand. But do they leave with good information on the importance of correct, consistent condom use?
-
When you counsel on protection against HIV and other sexually transmitted diseases (STDs), where does the female condom fit into your message? While the female condom represents a woman-controlled form of protection against HIV and other STDs, its use has lagged in the United States since its introduction in 1993.
-
These three studies published back to back in the Journal of Infectious Diseases serve to better characterize HPV infection in heterosexual men.
